Fiji vs Lebanon: HIV/AIDS deaths averted by antiretroviral therapy
Fiji
82.71 deaths
in 2024
Lebanon
101 deaths
in 2022
Fiji rank
128th
Lebanon rank
125th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Fiji
- Lebanon
How they compare
Lebanon currently reports 101 deaths against 82.71 deaths in Fiji, a difference of 18.29 deaths.
That makes Lebanon's figure about 1.2 times Fiji's.
Across all 33 years both countries report, Lebanon has been ahead every year.
Fiji ranks 128th and Lebanon ranks 125th of 157 countries.
Lebanon has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Fiji | Lebanon | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 0.4499 deaths | 23.6 deaths | 23.15 deaths | Lebanon |
| 2010s | 13.52 deaths | 68.4 deaths | 54.88 deaths | Lebanon |
| 2020s | 45.73 deaths | 98.67 deaths | 52.94 deaths | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Fiji or Lebanon?
- Lebanon, at 101 deaths against 82.71 deaths in Fiji as of 2022.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Fiji and Lebanon?
- 18.29 deaths, with Lebanon ahead.
- How many years of comparable data are there for Fiji and Lebanon?
- 33 years are reported by both, from 1990 to 2022.
- How do Fiji and Lebanon rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Fiji ranks 128th and Lebanon ranks 125th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.